HUP0103222A3 - Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders - Google Patents
Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disordersInfo
- Publication number
- HUP0103222A3 HUP0103222A3 HU0103222A HUP0103222A HUP0103222A3 HU P0103222 A3 HUP0103222 A3 HU P0103222A3 HU 0103222 A HU0103222 A HU 0103222A HU P0103222 A HUP0103222 A HU P0103222A HU P0103222 A3 HUP0103222 A3 HU P0103222A3
- Authority
- HU
- Hungary
- Prior art keywords
- glucocorticoid
- treatment
- hormone receptor
- metabolic disorders
- thyroid hormone
- Prior art date
Links
- 108090000079 Glucocorticoid Receptors Proteins 0.000 title 1
- 102100033417 Glucocorticoid receptor Human genes 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 208000030159 metabolic disease Diseases 0.000 title 1
- 102000004217 thyroid hormone receptors Human genes 0.000 title 1
- 108090000721 thyroid hormone receptors Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/90—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. amino-diphenylethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/56—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl groups, e.g. oxamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
- C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
- C07C69/736—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9816935.2A GB9816935D0 (en) | 1998-08-05 | 1998-08-05 | Novel glucocortoid and thyroid receptor ligands for the treatment of metabolic disorders |
| PCT/IB1999/001447 WO2000007972A1 (en) | 1998-08-05 | 1999-08-04 | Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0103222A2 HUP0103222A2 (hu) | 2002-01-28 |
| HUP0103222A3 true HUP0103222A3 (en) | 2002-12-28 |
Family
ID=10836671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0103222A HUP0103222A3 (en) | 1998-08-05 | 1999-08-04 | Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6492424B1 (hu) |
| EP (1) | EP1102739B1 (hu) |
| JP (1) | JP2002522407A (hu) |
| KR (1) | KR20010072113A (hu) |
| CN (1) | CN1311767A (hu) |
| AT (1) | ATE238267T1 (hu) |
| AU (1) | AU753376B2 (hu) |
| BG (1) | BG105214A (hu) |
| BR (1) | BR9912742A (hu) |
| CA (1) | CA2339194A1 (hu) |
| DE (1) | DE69907210T2 (hu) |
| DK (1) | DK1102739T3 (hu) |
| ES (1) | ES2193730T3 (hu) |
| GB (1) | GB9816935D0 (hu) |
| HU (1) | HUP0103222A3 (hu) |
| ID (1) | ID28805A (hu) |
| IL (1) | IL141106A0 (hu) |
| MX (1) | MXPA01001047A (hu) |
| NO (1) | NO20010610L (hu) |
| PL (1) | PL345824A1 (hu) |
| SE (1) | SE1102739T5 (hu) |
| SI (1) | SI20579A (hu) |
| SK (1) | SK942001A3 (hu) |
| TR (1) | TR200100274T2 (hu) |
| WO (1) | WO2000007972A1 (hu) |
| ZA (1) | ZA200100832B (hu) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL144765A0 (en) | 1999-03-01 | 2002-06-30 | Pfizer Prod Inc | Oxamic acids and derivatives as thyroid receptor ligands |
| US6790978B2 (en) | 1999-03-29 | 2004-09-14 | Novartis Ag | Thyromimetic organic compounds |
| US6599942B1 (en) | 1999-03-29 | 2003-07-29 | Novartis Ag | Thyromimetic organic compounds |
| GB9928805D0 (en) * | 1999-12-07 | 2000-02-02 | Karobio Ab | Compounds active at the Glucocorticoid and Thyroid Hormone Receptors |
| US6664291B2 (en) | 2000-03-31 | 2003-12-16 | Pfizer, Inc. | Malonamic acids and derivatives thereof as thyroid receptor ligands |
| DE10038007A1 (de) * | 2000-08-04 | 2002-02-14 | Bayer Ag | Neue Amino-und Amido-Diphenylether für Arzneimittel |
| EP1201660B1 (en) | 2000-10-30 | 2005-08-31 | Pfizer Products Inc. | Glucocorticoid receptor modulators |
| WO2002040018A1 (en) * | 2000-11-14 | 2002-05-23 | Alcon, Inc. | Treatment of glaucoma and ocular hypertension |
| GB0029102D0 (en) * | 2000-11-29 | 2001-01-10 | Karobio Ab | Compounds active at the glucocorticoid receptor |
| GB0029100D0 (en) * | 2000-11-29 | 2001-01-10 | Karobio Ab | Compounds active at the glucocorticoid receptor |
| US6583180B2 (en) | 2001-02-14 | 2003-06-24 | Abbott Laboratories | Glucocorticoid receptor modulators |
| US6777442B2 (en) * | 2001-03-12 | 2004-08-17 | Bayer Aktiengesellschaft | Diphenyl derivatives |
| GB0111861D0 (en) * | 2001-05-15 | 2001-07-04 | Karobio Ab | Novel compounds |
| US7279593B2 (en) | 2001-08-24 | 2007-10-09 | Karo Bio Ab | Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| GB0120691D0 (en) * | 2001-08-24 | 2001-10-17 | Karobio Ab | Novel Compounds |
| EP1430017A2 (en) | 2001-09-26 | 2004-06-23 | Theravance, Inc. | Substituted phenol compounds useful for anesthesia and sedation |
| ES2253495T3 (es) | 2001-09-26 | 2006-06-01 | Pfizer Products Inc. | Acidos indol carboxilicos como ligandos de receptores tiroideos. |
| EP1467730A4 (en) | 2002-01-22 | 2010-03-10 | Univ California | Non-steroid ligands for the glucocorticoid receptor, compositions and uses thereof |
| CA2473162A1 (en) * | 2002-01-30 | 2003-08-07 | Kissei Pharmaceutical Co., Ltd. | Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| GB0215978D0 (en) * | 2002-07-10 | 2002-08-21 | Karobio Ab | Novel compounds |
| AU2002951977A0 (en) | 2002-10-10 | 2002-10-24 | Leo Engineering Pty Ltd | Improvements to two-part vessels |
| EP2428516A1 (en) * | 2003-11-19 | 2012-03-14 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
| GB0406378D0 (en) * | 2004-03-22 | 2004-04-21 | Karobio Ab | Novel pharmaceutical compositions |
| MX2007014501A (es) * | 2005-05-26 | 2008-02-07 | Metabasis Therapeutics Inc | Tiromimeticos novedosos que contienen acido fosfinico. |
| CA2606499C (en) | 2005-05-26 | 2017-06-13 | Metabasis Therapeutics, Inc. | Thyromimetics for the treatment of fatty liver diseases |
| WO2009129225A1 (en) * | 2008-04-15 | 2009-10-22 | Osteogenex, Inc. | Compounds and methods for altering bone growth |
| WO2018094265A2 (en) | 2016-11-21 | 2018-05-24 | Viking Therapeutics, Inc. | Method of treating glycogen storage disease |
| EP3634426A4 (en) | 2017-06-05 | 2021-04-07 | Viking Therapeutics, Inc. | COMPOSITIONS FOR THE TREATMENT OF FIBROSIS |
| JP2021518403A (ja) | 2018-03-22 | 2021-08-02 | バイキング・セラピューティクス・インコーポレイテッド | 化合物の結晶形態及び化合物の結晶形態を生成する方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE159515T1 (de) * | 1992-07-21 | 1997-11-15 | Ciba Geigy Ag | Oxamidsäure-derivate als hypocholesterämische mittel |
| KR20010052431A (ko) * | 1998-06-08 | 2001-06-25 | 오테스코그 페르 | 당뇨병 치료제 |
-
1998
- 1998-08-05 GB GBGB9816935.2A patent/GB9816935D0/en not_active Ceased
-
1999
- 1999-08-04 WO PCT/IB1999/001447 patent/WO2000007972A1/en not_active Application Discontinuation
- 1999-08-04 CN CN99809310A patent/CN1311767A/zh active Pending
- 1999-08-04 SK SK94-2001A patent/SK942001A3/sk unknown
- 1999-08-04 JP JP2000563607A patent/JP2002522407A/ja active Pending
- 1999-08-04 CA CA002339194A patent/CA2339194A1/en not_active Abandoned
- 1999-08-04 KR KR1020017001279A patent/KR20010072113A/ko not_active Application Discontinuation
- 1999-08-04 HU HU0103222A patent/HUP0103222A3/hu unknown
- 1999-08-04 SI SI9920064A patent/SI20579A/sl unknown
- 1999-08-04 EP EP99936913A patent/EP1102739B1/en not_active Expired - Lifetime
- 1999-08-04 US US09/744,865 patent/US6492424B1/en not_active Expired - Fee Related
- 1999-08-04 BR BR9912742-3A patent/BR9912742A/pt not_active Application Discontinuation
- 1999-08-04 PL PL99345824A patent/PL345824A1/xx not_active Application Discontinuation
- 1999-08-04 ID IDW20010257A patent/ID28805A/id unknown
- 1999-08-04 DE DE69907210T patent/DE69907210T2/de not_active Expired - Fee Related
- 1999-08-04 DK DK99936913T patent/DK1102739T3/da active
- 1999-08-04 SE SE99936913T patent/SE1102739T5/xx unknown
- 1999-08-04 TR TR2001/00274T patent/TR200100274T2/xx unknown
- 1999-08-04 ES ES99936913T patent/ES2193730T3/es not_active Expired - Lifetime
- 1999-08-04 AT AT99936913T patent/ATE238267T1/de not_active IP Right Cessation
- 1999-08-04 IL IL14110699A patent/IL141106A0/xx unknown
- 1999-08-04 AU AU51881/99A patent/AU753376B2/en not_active Ceased
- 1999-08-04 MX MXPA01001047A patent/MXPA01001047A/es not_active IP Right Cessation
-
2001
- 2001-01-30 ZA ZA200100832A patent/ZA200100832B/xx unknown
- 2001-02-02 BG BG105214A patent/BG105214A/xx unknown
- 2001-02-05 NO NO20010610A patent/NO20010610L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1102739A1 (en) | 2001-05-30 |
| SE1102739T3 (hu) | 2003-08-12 |
| AU753376B2 (en) | 2002-10-17 |
| IL141106A0 (en) | 2002-02-10 |
| BG105214A (en) | 2001-12-29 |
| ID28805A (id) | 2001-07-05 |
| CN1311767A (zh) | 2001-09-05 |
| NO20010610D0 (no) | 2001-02-05 |
| CA2339194A1 (en) | 2000-02-17 |
| DK1102739T3 (da) | 2003-08-18 |
| JP2002522407A (ja) | 2002-07-23 |
| TR200100274T2 (tr) | 2001-09-21 |
| WO2000007972A1 (en) | 2000-02-17 |
| NO20010610L (no) | 2001-04-04 |
| SK942001A3 (en) | 2001-12-03 |
| SE1102739T5 (hu) | 2003-09-16 |
| PL345824A1 (en) | 2002-01-14 |
| MXPA01001047A (es) | 2002-09-02 |
| EP1102739B1 (en) | 2003-04-23 |
| ATE238267T1 (de) | 2003-05-15 |
| HUP0103222A2 (hu) | 2002-01-28 |
| DE69907210T2 (de) | 2004-02-19 |
| AU5188199A (en) | 2000-02-28 |
| ES2193730T3 (es) | 2003-11-01 |
| ZA200100832B (en) | 2001-10-31 |
| GB9816935D0 (en) | 1998-09-30 |
| SI20579A (sl) | 2001-12-31 |
| DE69907210D1 (de) | 2003-05-28 |
| KR20010072113A (ko) | 2001-07-31 |
| BR9912742A (pt) | 2001-05-02 |
| US6492424B1 (en) | 2002-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103222A3 (en) | Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders | |
| GB9927056D0 (en) | Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders | |
| EP1024146A4 (en) | USE OF SAPONIN AND STEROID COMPOUNDS FOR PREVENTING SENILITY AND NEW STEROID SAPONIN COMPOUNDS | |
| PL348817A1 (en) | Compositions and methods for the treatment of anorectal disorders | |
| IL138129A0 (en) | Therapy of estrogen associated disorders | |
| IL141403A0 (en) | Deleted adenoviruses and methods of making and administering the same | |
| HUP0103856A2 (hu) | Gyógyszerkészítmény akut rendellenességek kezelésére | |
| HK1040192A1 (zh) | 生物雌激素氨基磺酸酯在激素替代治療中的應用 | |
| EG21281A (en) | Device for mixing and dissolving solid in aliquid in particular for the production of phosphonitrogenous ferttilizers | |
| HK1041827B (zh) | 用於治療雌激素依賴性疾病的化合物以及製備和使用上述化合物的方法 | |
| IL133136A0 (en) | Use of leptin antagonists for the treatment of diabetes | |
| SG60203A1 (en) | Steroid compounds having contraceptive and anti-osteoporosis activity | |
| EP0800405A4 (en) | CONTINUOUS ADMINISTRATION OF LOW DOSES OF HORMONE PARATHYRO DIENNE OR ITS AGONIST | |
| GB9928805D0 (en) | Compounds active at the Glucocorticoid and Thyroid Hormone Receptors | |
| EP0981357A4 (en) | METHODS AND COMPOSITIONS APPLICABLE TO THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | |
| EP0754701A4 (en) | NEW PROGESTERONE COMPOUND AND ITS USE | |
| EP0979234A4 (en) | METHODS AND COMPOSITIONS APPLICABLE TO THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS | |
| HUP0102704A3 (en) | Meiosis regulating steroid compounds and use thereof | |
| PT1011678E (pt) | Utilização de mecamilamina para o tratamento de perturbações neuropsiquiátricas responsivas à nicotina. | |
| EP1077892A4 (en) | METHOD AND COMPOSITION FOR IMPROVING THE UNIFORMITY OF APPLICATION OF A SIZE | |
| AU2591800A (en) | Synthetic and therapeutic methods for the alpha and beta domains of metallothionein | |
| EP1112250A4 (en) | THERAPEUTIC COMPOUNDS AND RELATED METHODS | |
| GB2361535A8 (en) | Polymorphisms in the 5'leader cistron of the beta2-adrenergic receptor | |
| GB9523364D0 (en) | Metering spout bowl assembly | |
| ZA982360B (en) | Process and apparatus for the preparation of fine ores for direct reduction |